Under construction – not a live service
Sign in
Taking people in CanadaNo phase

Tests a brain implant that lets people control devices by thought

Tests a wireless brain implant placed by a robot in people with paralysis.

Plain-language title generated from the registry record
Registry title: CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

Key facts

Where
Toronto, CanadaSee the site

Where in Canada

  • University Health NetworkToronto, CanadaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Neuralink Corp
Trial code
NCT06700304
Record updated
31 May 2025
Original description
The CAN-PRIME Study is to test the safety and functionality of Neuralink's N1 Implant and R1 Robot in people who have difficulty moving their arms and legs (tetraparesis or tetraplegia). The N1 Implant is a small, wireless device placed in the skull. It connects to tiny threads inserted into the brain by the R1 Robot, which is a machine designed to carefully place these threads. This study will help researchers learn how well the implant and robot work and if they are safe for use.Read full original descriptionShow less

CAN-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

The CAN-PRIME Study is to test the safety and functionality of Neuralink's N1 Implant and R1 Robot in people who have difficulty moving their arms and legs (tetraparesis or tetraplegia). The N1 Implant is a small, wireless device placed in the skull. It connects to tiny threads inserted into the brain by the R1 Robot, which is a machine designed to carefully place these threads. This study will help researchers learn how well the implant and robot work and if they are safe for use.

Inclusion: Severe quadriplegia (tetraplegia) due to spinal cord injury or amyotrophic lateral sclerosis (ALS) for at least 1 year without improvement, where quadriplegia is defined as having very limited or no hand, wrist, and arm movement and all levels below; Life expectancy ≥ 12 months; Ability to communicate in English; Presence of a stable caregiver.

Exclusion: History of poorly controlled seizures or epilepsy; History of poorly controlled diabetes; Requires magnetic resonance imaging (MRI) for any ongoing medical conditions; Psychiatric or psychological disorder; Brain MRI demonstrating hemorrhage, tumor, distorted or adverse anatomy; Any condition which, in the opinion of the Investigator, would compromise your ability to safely participate in the study or undergo the implantation procedure; Moderate to high risk for serious perioperative adverse events; Active implanted devices; Morbid obesity (Body Mass Index > 40); Acquired or hereditary immunosuppression; Use of smoking tobacco or other tobacco products.

ClinicalTrials.gov NCT06700304